CRNX CRINETICS PHARMACEUTICALS INC Product Launches 8-K Filing 2024 - FDA Drug Approval Crinetics Pharmaceuticals announced that the FDA accepted its New Drug Application for paltusotine, aimed at treating acromegaly in adults.Get access to all SEC 8-K filings of the CRINETICS PHARMACEUTICALS INC